News & Updates

Crowding, mobility predict TB infection among kids

04 Dec 2024

A high prevalence of tuberculosis (TB) infection is seen among children and adolescents residing in rural Uganda, a study has found. Crowding and mobility are some of the factors associated with TB risk.

Crowding, mobility predict TB infection among kids

04 Dec 2024

Low BMD predicts death, infections in stroke patients

04 Dec 2024

Stroke patients who have low bone mineral density (BMD), particularly in the spine and femur, are at greater risk of mortality and urinary tract infection (UTI), reveals a study.

Low BMD predicts death, infections in stroke patients

04 Dec 2024

Nomogram identifies burned children at risk of infections

03 Dec 2024 by

A newly developed nomogram demonstrates its ability to predict the risk of healthcare-associated infections (HAIs) in burned children. This prediction model is based on factors such as larger burns, longer length of stay (LOS), and use of central venous catheter (CVC), among others.

Nomogram identifies burned children at risk of infections

03 Dec 2024

Why not metformin for long COVID in non-diabetics?

03 Dec 2024 by

Metformin prescribed within a week of SARS-CoV-2 infection was associated with a 53-percent reduction in long COVID or death over 6 months in patients without diabetes or prediabetes, as shown in a simulation study presented at IDWeek 2024.

Why not metformin for long COVID in non-diabetics?

03 Dec 2024

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024 by

Daily transcutaneous electrical nerve stimulation (TENS) therapy using a wearable device holds promise in alleviating pain, fatigue, and gait alterations in individuals with long COVID, as shown in a pilot study.

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024

7 days of antibiotics as effective as 14 days for bloodstream infections

02 Dec 2024 by

In the noninferiority BALANCE* trial, 7 days of antibiotic use is as effective as 14 days for treating bloodstream infections (BSIs) in hospitalized patients, drawing renewed interest from clinicians attending IDWeek 2024.

7 days of antibiotics as effective as 14 days for bloodstream infections

02 Dec 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024 by

The likelihood of survival at 30 days among patients with CRE infections is similar for those who receive ceftazidime-avibactam or meropenem-vaborbactam. However, recurrent infections and the emergence of resistance are observed less frequently with the latter carbapenem/BLI combination, as suggested by a prospective observational study presented at IDWeek 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

29 Nov 2024 by

For the screening and diagnosis of paediatric Helicobacter pylori infection at a tertiary centre in Singapore, endoscopies are often skipped in favour of a “test-and-treat” approach based on noninvasive testing, a practice that deviates from recommended protocols.